Skip to main content

MoneyWorks4Me

Indoco Remedies informs about board meeting

04 Jan 2022 Evaluate

Pursuant to Regulation 29 read with Regulation 47 of SEBI (Listing Obligations and Disclosure Requirement) Regulation 2015, Indoco Remedies has informed that a meeting of the Board of Directors of the Company will be held on Tuesday, 1st February, 2022 to consider and approve, the un-audited financial results of the Company for the quarter ended December 31, 2021.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1793.80
Dr. Reddys Labs. 1357.50
Cipla 1369.20
Lupin 2009.70
Zydus Lifesciences 1246.85
View more..